Sat.Sep 21, 2024

article thumbnail

Now Trending: Fall Vaccine Hesitancy, AI in Respiratory Care

Drug Topics

Check out this recap of articles published on our sister sites during the past week.

Vaccines 187
article thumbnail

NCPA Continues Push for Congressional PBM, Health Care Reform

Pharmacy Times

As the end of this Congress approaches, the National Community Pharmacists Association is lobbying members to pass pharmacy benefit manager reforms.

132
132
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: First Opinion readers on clinical trials in Africa, compounded semaglutide, depressed mice, and more

STAT

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.

article thumbnail

Small Doses: September 16 to September 20

Drug Topics

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

98
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Australian demand for overdose drug naloxone more than doubles after spike in synthetic opioid deaths

The Guardian - Pharmaceutical Industry

Take Home Naloxone program, which allows access without a prescription, sees rise in use after multiple reports of people who unknowingly used laced drugs and died Follow our Australia news live blog for latest updates Get our breaking news email , free app or daily news podcast Demand for a life-saving opioid overdose drug has doubled in one year as a “whole new cohort” of stimulant and hallucinogenic users, fearful of taking lethally laced narcotics, have rushed to get the medication.

87
article thumbnail

A Look Into Bioprocessing Innovations for Downstream Processing Efficiencies (BIO 2024)

BioPharm

Ecolab's Hayley Crowe, executive vice-president and general manager Global Life Sciences sat down at BIO 2024 to discuss technology innovations and how they have enhanced downstream bioprocessing.

52